Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Balcerzak

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Hematology|August 1, 1982
Human macrophage hemoglobin-iron metabolism in vitroG Custer, S Balcerzak, J Rinehart
Seminars in Oncology|October 1, 1990
A comprehensive phase I and II clinical investigation of fludarabine phosphateM Grever, J Leiby, E Kraut, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group studyC J Fabian, S Rasmussen, R Stephens, et al.
Cancer|October 1, 1975
Prognostic factors in multiple myelomaR Alexanian, S Balcerzak, J D Bonnet, et al.
Cancer Genetics and Cytogenetics|November 14, 1997
Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group StudyA N Mohamed, M M Zalupski, J R Ryan, et al.
American Journal of Clinical Oncology|December 1, 1982
Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia. A Southwest Oncology Group StudyF S Morrison, R Benjamin, M Amare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trialB W Dana, S Dahlberg, T P Miller, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Hematology|August 1, 1982
Human macrophage hemoglobin-iron metabolism in vitroG Custer, S Balcerzak, J Rinehart
Seminars in Oncology|October 1, 1990
A comprehensive phase I and II clinical investigation of fludarabine phosphateM Grever, J Leiby, E Kraut, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group studyC J Fabian, S Rasmussen, R Stephens, et al.
Cancer|October 1, 1975
Prognostic factors in multiple myelomaR Alexanian, S Balcerzak, J D Bonnet, et al.
Cancer Genetics and Cytogenetics|November 14, 1997
Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group StudyA N Mohamed, M M Zalupski, J R Ryan, et al.
American Journal of Clinical Oncology|December 1, 1982
Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia. A Southwest Oncology Group StudyF S Morrison, R Benjamin, M Amare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trialB W Dana, S Dahlberg, T P Miller, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Cancer Treatment Reports|February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomasJ A Gottlieb, R S Benjamin, L H Baker, et al.
Pageof 1